Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 73, Issue 3, Pages 529-535
Publisher
BMJ
Online
2014-01-09
DOI
10.1136/annrheumdis-2013-204575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FRI0245 Prospective follow-up of tocilizumab treatment in 1100 patients with refractory rheumatoid arthritis: tolerance data from the french registry regate (registry –roactemra)
- (2014) J. Morel et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
- (2014) Cécile Gaujoux-Viala et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2014) Jackie L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
- (2014) Takao Koike et al. Modern Rheumatology
- Tofacitinib for Treatment of Rheumatoid Arthritis
- (2013) Chadi Rakieh et al. ADVANCES IN THERAPY
- EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
- (2013) N Duru et al. ANNALS OF THE RHEUMATIC DISEASES
- Proposal for a new nomenclature of disease-modifying antirheumatic drugs: Table 1
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
- (2013) Pavel Horák et al. CLINICAL RHEUMATOLOGY
- Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster
- (2013) Kevin L. Winthrop et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis
- (2013) Y Hishitani et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry
- (2013) S. Godot et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
- (2013) P. Raaschou et al. BMJ-British Medical Journal
- Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study
- (2012) Kevin L. Winthrop et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2012) James B Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register
- (2012) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study
- (2012) Elizabeth V Arkema et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycobacterial diseases and antitumour necrosis factor therapy in USA
- (2012) KL Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
- (2012) Kevin Haynes et al. ARTHRITIS AND RHEUMATISM
- Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: Drug-specific comparisons in the Swedish Biologics Register
- (2012) Julia F. Simard et al. ARTHRITIS AND RHEUMATISM
- Association between anti-TNF-α therapy and all-cause mortality
- (2012) Lisa J. Herrinton et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
- (2012) L. K. Mercer et al. RHEUMATOLOGY
- Risk of Mortality, Fatal Infection, and Fatal Malignancy Related to Use of Anti-Tumor Necrosis Factor-α Biologics by Rheumatoid Arthritis Patients
- (2012) Veena Thyagarajan et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs
- (2012) Bao-Anh Nguyen-Khoa et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis
- (2012) Jeffrey R. Curtis et al. ARTHRITIS CARE & RESEARCH
- The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
- (2011) J. R. Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
- (2011) R. Davies et al. ANNALS OF THE RHEUMATIC DISEASES
- The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study
- (2011) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
- (2011) A. Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
- (2011) T. Koike et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
- (2011) Lotta Ljung et al. ARTHRITIS AND RHEUMATISM
- Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
- (2011) Carlos G. Grijalva et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety
- (2011) Y. KOMANO et al. JOURNAL OF RHEUMATOLOGY
- TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis
- (2011) Michael A. Lane et al. MEDICINE
- Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
- (2011) Wassila Amari et al. RHEUMATOLOGY
- The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. RHEUMATOLOGY
- Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
- (2010) J. D. Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis
- (2010) J. Sokolove et al. ANNALS OF THE RHEUMATIC DISEASES
- Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
- (2010) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
- (2010) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
- (2010) Mark Lunt et al. ARTHRITIS AND RHEUMATISM
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- The incidence of gastrointestinal perforations among rheumatoid arthritis patients
- (2010) Jeffrey R. Curtis et al. ARTHRITIS AND RHEUMATISM
- Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers
- (2010) A. Strangfeld et al. RHEUMATOLOGY
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
- (2010) J. B. Galloway et al. RHEUMATOLOGY
- Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists
- (2010) Loreto Carmona et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
- (2009) J D Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Demyelinating events in rheumatoid arthritis after drug exposures
- (2009) S. Bernatsky et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada
- (2009) Paul Brassard et al. ARTHRITIS AND RHEUMATISM
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry
- (2009) Francesca Bobbio Pallavicini et al. AUTOIMMUNITY REVIEWS
- Herpes Zoster Risk Factors in a National Cohort of Veterans with Rheumatoid Arthritis
- (2009) Jay R. McDonald et al. CLINICAL INFECTIOUS DISEASES
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
- (2009) T. KOIKE et al. JOURNAL OF RHEUMATOLOGY
- Initiation of rheumatoid arthritis treatments and the risk of serious infections
- (2009) Carlos G. Grijalva et al. RHEUMATOLOGY
- European biologicals registers: methodology, selected results and perspectives
- (2008) A Zink et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
- (2008) J Askling et al. ANNALS OF THE RHEUMATIC DISEASES
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started